sodium-oxybate has been researched along with Feeding-and-Eating-Disorders* in 3 studies
1 trial(s) available for sodium-oxybate and Feeding-and-Eating-Disorders
Article | Year |
---|---|
Night eating syndrome. Preliminary results.
Clinical aspects of the "night eating syndrome" (NES) are described. Recent studies, also referred to in the present report, have revealed certain triggering factors of this syndrome, but do not reveal the nature of the relationship between awakening and compulsory need for food. According to the psychodynamic interpretation, these subjects eat at night to replace dreaming, to which they offer strong resistance, whilst according to the psychobiological interpretation, motivational stimuli develop the irresistible and repeated desire for food. Within a post-rational cognitive theoretical model, the compulsion to food would be the mode through which subjects obtain a modified conscious state necessary to appease the suffering due to an experience of emptiness and incapacity. Psychological support associated with pharmacological treatment (benzodiazepine, gamma-hydroxybutyric acid) has been shown, in a personal series, to be effective both upon the sleep disorder and craving. Topics: Adult; Aged; Anxiety; Compulsive Behavior; Drug Therapy, Combination; Feeding and Eating Disorders; Female; Humans; Male; Motivation; Oxazepam; Psychological Theory; Psychotherapy; Sleep Disorders, Circadian Rhythm; Sodium Oxybate; Treatment Outcome | 2000 |
2 other study(ies) available for sodium-oxybate and Feeding-and-Eating-Disorders
Article | Year |
---|---|
Sexsomnia and sleep eating secondary to sodium oxybate consumption.
Topics: Adjuvants, Anesthesia; Adult; Feeding and Eating Disorders; Female; Humans; Narcolepsy; Parasomnias; Sodium Oxybate | 2016 |
Sodium oxybate-induced sleep driving and sleep-related eating disorder.
Hypnosedative-induced complex behaviors have gained increased attention in recent years as a potential complication of benzodiazepines and benzodiazepine-receptor agonist use. Sodium oxybate (SO), the sodium salt of γ-hydroxybutyrate, an inhibitory neurotransmitter, has been associated with dose-dependent rates of somnambulism; however, there is limited information about complex motor behaviors with SO. We describe a patient with narcolepsy-cataplexy who experienced one episode of sleep-driving and at least two sleep-related eating episodes with therapeutic doses of SO. Topics: Adjuvants, Anesthesia; Adult; Automobile Driving; Feeding and Eating Disorders; Humans; Male; Narcolepsy; Parasomnias; Sleep Wake Disorders; Sodium Oxybate | 2011 |